Maria-Ceu Machado, president of INFARMED the National Authority of Medicines and Health Products, stresses the importance of healthcare restructuring and streamlining work practices in Portugal. In her first year as president, Maria and her team have brought in new rules on medicine approval times, confronted challenges in the reference pricing system and sought to improve cooperation and collaboration between government and industry.
Can you detail the milestones have you had over the past year in charge of INFARMED?
"The creation of the technologies evaluation system, SINATS, in 2015 is one of the most important milestones for Portugal and has developed extensively in the past year."
